GB2441600A - A purified arabinogalactan-protein (AGP) composition. - Google Patents

A purified arabinogalactan-protein (AGP) composition.

Info

Publication number
GB2441600A
GB2441600A GB0704734A GB0704734A GB2441600A GB 2441600 A GB2441600 A GB 2441600A GB 0704734 A GB0704734 A GB 0704734A GB 0704734 A GB0704734 A GB 0704734A GB 2441600 A GB2441600 A GB 2441600A
Authority
GB
United Kingdom
Prior art keywords
protein
agp
inhibition
composition
purified arabinogalactan
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
GB0704734A
Other versions
GB0704734D0 (en
Inventor
Sudershan Kumar Arora
Vandita Srivastava
Sameer Shankar Walunj
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lupin Ltd
Original Assignee
Lupin Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/931,814 external-priority patent/US7601368B2/en
Application filed by Lupin Ltd filed Critical Lupin Ltd
Publication of GB0704734D0 publication Critical patent/GB0704734D0/en
Publication of GB2441600A publication Critical patent/GB2441600A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/66—Papaveraceae (Poppy family), e.g. bloodroot
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Botany (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

A purified Arabinogalactan-Protein (AGP) composition isolated through a selective method from the leaves and/or stems of Argemone mexicana plant is described. Also described is a purified Arabinogalactan-Protein (AGP composition isolated from the leaves and/or stems of Argemone mexicana plant, which has one or more of the following effects: immunosuppression, lymphoproliferation inhibition, cytokine modulation such as IL-2 inhibition, IFN- q inhibition, or IL-10 induction; keratinocyte proliferation inhibition, keratolytic activity and inhibitory activity in louse Ear Swelling test (MEST).
GB0704734A 2004-09-01 2007-03-12 A purified arabinogalactan-protein (AGP) composition. Withdrawn GB2441600A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/931,814 US7601368B2 (en) 2004-09-01 2004-09-01 Purified Arabinogalactan-Protein (AGP) composition useful in the treatment psoriasis and other disorders
PCT/IN2005/000132 WO2006025068A1 (en) 2004-09-01 2005-04-26 A purified arabinogalactan-protein (agp) composition

Publications (2)

Publication Number Publication Date
GB0704734D0 GB0704734D0 (en) 2007-04-18
GB2441600A true GB2441600A (en) 2008-03-12

Family

ID=39106233

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0704734A Withdrawn GB2441600A (en) 2004-09-01 2007-03-12 A purified arabinogalactan-protein (AGP) composition.

Country Status (1)

Country Link
GB (1) GB2441600A (en)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030194456A1 (en) * 2002-01-10 2003-10-16 Lupin Limited Herbal composition for treating various disorders including psoriasis, a process for preparation thereof and method for treatment of such disorders

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030194456A1 (en) * 2002-01-10 2003-10-16 Lupin Limited Herbal composition for treating various disorders including psoriasis, a process for preparation thereof and method for treatment of such disorders

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
CMLS Cellular & Molecular Life Sciences (2001); Vol 58, pp 1399-1417, "Arabinogalactan-proteins: Structure, expression and function", Showalter *
Indian Drugs (2001); Vol 38, pp 288-293, "Preliminary phytochemical investigation...", Patil et al *

Also Published As

Publication number Publication date
GB0704734D0 (en) 2007-04-18

Similar Documents

Publication Publication Date Title
MX2007002428A (en) A purified arabinogalactan-protein (agp) composition.
WO2003027247A3 (en) Modulation of stem cells using zinc finger proteins
MX2009009225A (en) Definitive endoderm.
EP1408064A4 (en) Open-ring copolymer, hydrogenated open-ring copolymer, processes for production of both, and compositions
TW200621253A (en) 2-amido-thiazole-based compounds exhibiting atp-utilizing enzyme inhibitory activity, and compositions, and uses thereof
NO20013003L (en) Quinoline derivatives
YU17402A (en) Novel spiroheterocyclic compounds useful as reversible inhibitors of cysteine proteases
AU7926098A (en) Methods and means for control of flowering in plants
AU3396800A (en) Selective removal of nitrogen from natural gas by pressure swing adsorption
EP2311949A3 (en) Antisense compounds targeted to connexins and methods of use thereof
RS20060320A (en) Substituted indazole-o-glucosides
SG130189A1 (en) Substituted indole-o-glucosides
EP2384772A3 (en) Antimicrobial lenses, processes to prepare them and methods of their use
WO2003039545A3 (en) Carboline derivatives as inhibitors of ikb in the treatment of multiple myeloma and others cancers
DK1399551T3 (en) Process for purifying bacterial cells and cellular components
AU2003247279A1 (en) Furancarboxamides
YU2500A (en) Alatrofloxacin parenteral compositions
AU2001265828A1 (en) Steeping process
WO2005001039A3 (en) Ribozyme-regulated small inhibitory rna (sirna) production and methods of use thereof
GB2441600A (en) A purified arabinogalactan-protein (AGP) composition.
WO2002001951A3 (en) Optically pure(-) clethodim, compositions and methods for controlling plant growth comprising the same
WO2005032595A3 (en) Methods and compositions for the inhibition of stat5 in prostate cancer cells
WO2002022848A3 (en) Compositions comprising mixtures of human cytokines and methods of producing the same
EP1307096A4 (en) Compositions and methods for preserving plants
PL1664307T3 (en) Novel endosperm-specific plant promoter for cultivated plants

Legal Events

Date Code Title Description
WAP Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1)